Your session is about to expire
← Back to Search
Medical Cannabis for Chronic Pain (OMNI-Can Trial)
OMNI-Can Trial Summary
This trial will test the effectiveness and safety of medical cannabis for various chronic medical conditions.
OMNI-Can Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOMNI-Can Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OMNI-Can Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am over 18 or have parental/legal guardian consent.I am willing to complete online surveys for this study.I do not have active thoughts of suicide or severe mental health issues that could worsen with cannabis.You are currently breastfeeding.I have a condition that qualifies for medical marijuana.
- Group 1: Life-Threatening Conditions
- Group 2: COVID-19 / SARS-CoV-2
- Group 3: Cannabis users
- Group 4: Cancer prevention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this a groundbreaking clinical trial?
"Presently, 31 active trials for Cannabis, Medical are scattered across 32 cities and 5 countries. It all started with a 200-patient trial conducted by Jazz Pharmaceuticals in 2015; since then 60 similar studies have concluded. This particular experiment made its way through the Phase 2 & 3 drug approval process."
What is the total population size for this clinical research project?
"Affirmative, clinicaltrials.gov displays that this investigation—initially published on December 1st 2018—is presently looking for volunteers. Two hundred thousand subjects need to be enrolled from 16 distinct locations."
Are there any remaining vacancies for this experiment in human subjects?
"This clinical study is actively looking for participants, as indicated on the information posted to clinicaltrials.gov. The trial was initiated on December 1st 2018 and has had its details amended more recently on May 29th 2022."
How widely spread is the implementation of this clinical trial?
"At the moment, this clinical trial is being managed across 16 sites located in various cities, including Fort Lauderdale, Boca Raton and Merritt Island. For convenience sake, it may be useful to select a clinic that requires minimal travel if you wish to enroll."
Could you please elucidate the potential risks of Medical Cannabis to patients?
"Our team at Power has assigned a safety rating of 2 to cannabis-based medicine, as it is currently undergoing Phase 2 testing and there is limited evidence regarding its efficacy."
Have there been other scholarly investigations into the therapeutic efficacy of Cannabis?
"At present, there are 31 active clinical trials concerning Cannabis Medical. Of those, 3 of them are in their final phase. Most of the sites conducting these experiments can be found in Hartford, Connecticut; however, that number rises to 46 when accounting for other locations across America."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger